The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury
Abstract
Excessive production of reactive oxygen species (ROS) after cerebral ischemia and reperfusion is implicated in brain damage through different cellular and molecular mechanisms, and it is further aggravated by impaired cellular antioxidant defense systems under ischemic conditions. Therapeutic strategies based on exogenous delivery of the native form of superoxide dismutase (SOD), a free radical scavenger, are limited because of its short half‐life (~6 min) in vivo and poor permeability across theblood‐brain‐barrier (BBB). We encapsulated SOD in biodegradable poly(D,L‐lactideco‐glycolide) nanoparticles (SOD‐NPs) and tested their efficacy in a rat focal cerebral ischemia‐reperfusion injury model. We hypothesized that localized brain delivery of SOD‐NPs would sustain the protective effect of SOD by neutralizing the deleterious effects of ROS formed following ischemia‐reperfusion. SOD‐NPs were administered at the time of reperfusion via the intracarotid route to maximize their localization in the brain. Animals receiving SOD‐NPs (10,000 U of SOD/ kg) demonstrated a 65% reduction in infarct volume, whereas an equivalent dose of SOD in solution (SOD– Sol) increased it by 25% over saline control (P<0.001; data at 6 h following reperfusion). Control NPs alone or mixed with SOD‐Sol were ineffective in reducing infract volume, with results similar to saline control, indicating the protective effect of the encapsulated enzyme. SOD‐NPs maintained BBB integrity, thereby preventing edema, reduced the level of ROS formed following reperfusion, and protected neurons from undergoing apoptosis. Animals treated with SOD‐NPs demonstrated greater survival than those with saline control (75% vs. 0% at 28 days) and later regained most vital neurological functions. SOD‐NPs may be an effective treatment option in conjunction with a thrombolytic agent for stroke patients.— Reddy, M. K., Labhasetwar, V. Nanoparticle‐mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia‐reperfusion injury. FASEB J. 23, 1384–1395 (2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Transduced Tat-SOD Fusion Protein Protects Against Ischemic Brain Injury
Kim, D. W., Eum, W. S., Jang, S. H., Kim, S. Y., Choi, H. S., Choi, S. H., An, J. J., Lee, S. H., Lee, K. S., Han, K., et al. (2005) · Molecules and Cells · doi:10.1016/s1016-8478(23)13141-4 · Cited by 62
RetractedReversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463 · cited 1×
“Transient focal cerebral ischemia was accomplished by middle cerebral artery occlusion, as reported previously (19).”
MethodMechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Cuzzocrea, S., Riley, D. P., Caputi, A. P., & Salvemini, D. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01484-4 · Cited by 1,087 · cited 1×
“hydrogen peroxide by scavenging the superoxide radical produced during reperfusion, thus overwhelming the endogenous hydrogen peroxide scavengers (catalase and glutathione peroxidase) and exacerbating cerebral injury (29).”
BackgroundA peptide carrier for the delivery of biologically active proteins into mammalian cells
Morris, M. C., Depollier, J., Mery, J., Heitz, F., & Divita, G. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1173 · Cited by 1,018
Pathophysiology, Clinical Manifestations, and Prevention of Ischemia-Reperfusion Injury
Collard, C. D., & Gelman, S. (2001) · Anesthesiology · doi:10.1097/00000542-200106000-00030 · Cited by 661
Oxidants, antioxidants and the ischemic brain
Warner, D. S., Sheng, H., & Batinić-Haberle, I. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01022 · Cited by 598
Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles
Prabha, S., Zhou, W.-Z., Panyam, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00315-0 · Cited by 553
Self-citationZambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Self-citationTreatment of stroke in rat with intracarotid administration of marrow stromal cells
Li, Y., Chen, J., Wang, L., Lu, M., & Chopp, M. (2001) · Neurology · doi:10.1212/wnl.56.12.1666 · Cited by 431
Antioxidant strategies in the treatment of stroke
Margaill, I., Plotkine, M., & Lerouet, D. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.003 · Cited by 405
Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies
Pan, J., Konstas, A.-A., Bateman, B., Ortolano, G. A., & Pile-Spellman, J. (2007) · Neuroradiology · doi:10.1007/s00234-006-0183-z · Cited by 390
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. (2007) · Neurosurgical Focus · doi:10.3171/foc.2007.22.5.5 · Cited by 357
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
Rao, K. S., Reddy, M. K., Horning, J. L., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.08.004 · Cited by 314
Self-citationSchmid-Elsaesser, R., Zausinger, S., Hungerhuber, E., Baethmann, A., & Reulen, H.-J. (1998) · Stroke · doi:10.1161/01.str.29.10.2162 · Cited by 289
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00029-7 · Cited by 273
Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation
Yasui, K., & Baba, A. (2006) · Inflammation Research · doi:10.1007/s00011-006-5195-y · Cited by 273
Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats.
Imaizumi, S., Woolworth, V, Fishman, R. A., & Chan, P. H. (1990) · Stroke · doi:10.1161/01.str.21.9.1312 · Cited by 267
Reperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic Horizon
Jean, W. C., Spellman, S. R., Nussbaum, E. S., & Low, W. C. (1998) · Neurosurgery · doi:10.1097/00006123-199812000-00076 · Cited by 264
Sugawara, T., Noshita, N., Lewén, A., Gasche, Y., Ferrand-Drake, M., Fujimura, M., Morita-Fujimura, Y., & Chan, P. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00209.2002 · Cited by 264
Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows.
Kuroda, S., & Siesjö, B. K. (1997) · PubMed · Cited by 263
In vivo MRI of brain inflammation in human ischaemic stroke
Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H.-P., Modder, U., & Jander, S. (2004) · Brain · doi:10.1093/brain/awh191 · Cited by 226
Nilupul Perera, M., Ma, H. K., Arakawa, S., Howells, D. W., Markus, R., Rowe, C. C., & Donnan, G. A. (2006) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2005.07.005 · Cited by 218
Gürsoy-Özdemir, Y., Bolay, H., Saribaş, O., & Dalkara, T. (2000) · Stroke · doi:10.1161/01.str.31.8.1974 · Cited by 196
Buonocore, G., & Groenendaal, F. (2007) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2007.01.020 · Cited by 148
Superoxide Dismutase-Loaded PLGA Nanoparticles Protect Cultured Human Neurons Under Oxidative Stress
Reddy, M. K., Wu, L., Kou, W., Ghorpade, A., & Labhasetwar, V. D. (2008) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-008-8232-1 · Cited by 146
Self-citationWhich Targets Are Relevant for Therapy of Acute Ischemic Stroke?
Heiss, W., Thiel, A., Grond, M., & Graf, R. (1999) · Stroke · doi:10.1161/01.str.30.7.1486 · Cited by 136
Shimamura, M., Sato, N., Oshima, K., Aoki, M., Kurinami, H., Waguri, S., Uchiyama, Y., Ogihara, T., Kaneda, Y., & Morishita, R. (2004) · Circulation · doi:10.1161/01.cir.0000109496.82683.49 · Cited by 117
Evaluating therapeutic targets for reperfusion‐related brain hemorrhage
Maier, C. M., Hsieh, L. B., Crandall, T., Narasimhan, P., & Chan, P. H. (2006) · Annals of Neurology · doi:10.1002/ana.20850 · Cited by 103
Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion
He, Y., Hsu, C. Y., Ezrin, A. M., & Miller, M. S. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.1.h252 · Cited by 103
Tsubokawa, T., Jadhav, V. R., Solaroğlu, İ., Shiokawa, Y., Konishi, Y., & Zhang, J. H. (2007) · Stroke · doi:10.1161/01.str.0000257978.70312.1d · Cited by 100
Acute Ischemic Stroke Treatment in 2007
Goldstein, L. B. (2007) · Circulation · doi:10.1161/circulationaha.106.670885 · Cited by 100
Cerebral Edema After Temporary and Permanent Middle Cerebral Artery Occlusion in the Rat
Slivka, A. P., Murphy, E. J., & Horrocks, L. A. (1995) · Stroke · doi:10.1161/01.str.26.6.1061 · Cited by 77
Choi‐Kwon, S., Park, K., Lee, H.-J., Park, M., Lee, J.-H., Jeon, S.-E., Choe, M., & Park, K.-C. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.05.004 · Cited by 74
Anderson, H. A., Englert, R. P., Gürsel, İ., & Shacter, E. B. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401013 · Cited by 66
Liposomal antioxidants in combating ischemia-reperfusion injury in rat brain
Sinha, J., Das, N., & Basu, M. K. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00060-9 · Cited by 53
Goto, H., Fujisawa, H., Oka, F., Nomura, S., Kajiwara, K., Kato, S., Fujii, M., Maekawa, T., & Suzuki, M. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0183 · Cited by 43
Kitagawa, K., Matsumoto, M., Kuwabara, K., Ohtsuki, T., & Hori, M. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200110000-00008 · Cited by 39
Brazil, M. I. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd720 · Cited by 34
Therapy for early reperfusion after stroke
Jüttler, E., Köhrmann, M., & Schellinger, P. D. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0721 · Cited by 27
Cited by
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Nance, E. A., Woodworth, G. F., Sailor, K. A., Shih, T.-Y., Xu, Q., Swaminathan, G., Xiang, D., Eberhart, C., & Hanes, J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003594 · Cited by 649
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558
“A previous study also found an increase in the size of the nanoparticles when measured by DLS.(27)”
MethodDrug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554
Metadata
- Authors
- Reddy, M. K., & Labhasetwar, V.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-01-05
- Volume
- 23
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2158416613
- Cited by
- 264
- References
- 41
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.